ArticleInfection and drug resistance2025
Disseminated Pyrazinamide-Resistant Mycobacterium Bovis in an AIDS Patient: The Role of Molecular Diagnosis and Optimized Therapy.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Zoonotic Tuberculosis as a One Health Challenge: Global Evidence, Transmission Dynamics, and Policy Gaps in Indonesia.Veterinary sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disseminated Mycobacterium bovis (M. bovis) infection is a rare but serious complication in immunocompromised individuals, particularly in those with advanced HIV/AIDS. Diagnosis is often delayed owing to overlapping clinical features with those of other mycobacterial infections. We report a case of disseminated M. bovis infection in a severely immunocompromised patient with AIDS. Rapid identification was achieved using molecular diagnostic techniques, specifically fluorescent PCR melting curve analysis, which enabled timely adjustments to antimicrobial therapy. The patient showed significant clinical improvement and resolution of symptoms. This case underscores the importance of early molecular diagnostics and tailored therapeutic strategies for managing opportunistic infections, such as M. bovis, in patients with HIV/AIDS. These findings highlight the need for broader implementation of advanced diagnostic tools to improve outcomes and mitigate the risks of treatment failure and drug resistance in vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.